delete The Medicines (Sale or Supply) (Miscellaneous Provisions) Amendment Regulations 2000
These regulations amend the Medicines (Sale or Supply) (Miscellaneous Provisions) Regulations 1980 by inserting a new paragraph 2G restricting mepyramine maleate products sold outside registered pharmacies (general sales) to a maximum pack size of 20 grams. The amendment limits the quantity of this antihistamine available through non-pharmacy retail outlets.
This regulation imposes an arbitrary 20-gram pack size restriction on mepyramine maleate products in general sales outlets, contradicting the foundational safety determination that placed this product on the general sale list. If a product is deemed safe enough for retail sale without pharmacy supervision, restricting pack size is paternalistic overreach that denies consumers the freedom to purchase quantities suited to their needs. It reduces consumer welfare, creates unnecessary compliance burdens for retailers, and restricts supply without demonstrable safety benefit that isn't already achieved by the GSL classification itself. Such micromanagement of pack sizes reflects the regulatory excess Britain should shed as a post-Brexit advantage.